Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
shareholder activism
Pharma
Catalent turns to Elliott after 2023 earnings disappoint
After a tumultuous year of manufacturing hiccups, executive turnover and dwindling revenues, Catalent is linking up with Elliott Management.
Fraiser Kansteiner
Aug 30, 2023 9:41am
Sarissa Capital fights for spots on Alkermes' board
Jun 12, 2023 9:45am
AZ's CEO Pascal Soriot fights investor skepticism—yet again
Apr 27, 2023 10:25am
Activist investor agitates for big changes after new Bayer CEO
Apr 21, 2023 10:24am
Bayer faces yet another round of activist investor pressure
Feb 7, 2023 7:33am
Bayer chairman under fire amid investor push for break-up
Jan 23, 2023 11:20am